ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
The NHS leadership seem more interested in policing language than improving either health care or the quality of management ...
London, UK, Wednesday 22 January 2025 – AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the ...
Vertex Pharmaceuticals Inc. (VRTX), a commercial-stage global biotechnology company, announced Friday a reimbursement agreement with ...
A consultation from the National Institute for Health and Care Excellence (NICE) and NHS England (NHSE) has proposed what amounts to an explicit, third threshold for cost-effectiveness to be used ...
New guidelines from the National Institute for Health and Care Excellence (NICE) focus on early identification of at-risk individuals to help reduce gambling-related harm in the UK. Measures ...
by the National Institute for Health and Care Excellence (Nice). The EGFR protein controls cell growth and survival. The mutation is common in NSCLC and causes abnormal cell growth. According to ...
Gilead Sciences and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel; axi-cel) for routine ...
Staffers have been advised to stop using words such as "passengers" and "pregnant woman" by Network Rail, a government-owned ...
The U.K.’s National Institute for Health and Care Excellence (NICE) historically relies on cost savings to vet novel medical ...
The National Institute for Health and Care Excellence (NICE) has approved a one-off gene editing therapy to treat severe sickle cell disease (SCD) in people 12 years and over. In final draft guidance1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results